Kanojia N

About

Research Interest

My major research interests include understanding the molecular aspects of neurological disease severity, variable drug- response via pharmacogenetics approach. I have a special interest and inclination towards the understanding of neuroendocrine biology, especially focusing on endocrine abnormalities in patients with neurological disorder. With more than of 7 years of research experience in the field of pharmacogenomics and molecular biology, I have gained good command over several Molecular Biology techniques, Data Analysis, and Scientific Writing.

Employment

• Delhi Technological University VISITING GUEST FACULTY
  2022 - 2022
• CSIR Institute of Genomics & Integrative Biology
  2013 - 2022

Education

• CSIR Institute of Genomics & Integrative Biology PhD IN SCIENCE
  2015 - 2022
• University of Delhi MASTER OF SCIENCE
  2011 - 2013
• University of Delhi BACHELOR OF SCIENCE
  2008 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Effect of antiepileptic drug monotherapy on endogenous sex hormonal profile in men and women with epilepsy
  Epilepsy & Behavior 2025 DOI: 10.1016/j.yebeh.2024.110220
  +Save
• Valproic acid-induced upregulation of multidrug efflux transporter ABCG2/BCRP via PPARα-dependent mechanism in human brain endothelial cells
  Molecular Pharmacology 2022 DOI: 10.1124/molpharm.122.000568
  +Save
• Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility.
  Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2022 DOI: 10.1016/j.meegid.2022.105299
  +Save
• Multidrug efflux transporter ABCG2: expression and regulation.
  Cellular and molecular life sciences : CMLS 2021 DOI: 10.1007/s00018-021-03901-y
  +Save
• Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery.
  ACS chemical neuroscience 2019 DOI: 10.1021/acschemneuro.9b00343
  +Save
• Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
  International journal of molecular sciences 2019 DOI: 10.3390/ijms20081993
  +Save
• In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2.
  Molecules (Basel, Switzerland) 2017 DOI: 10.3390/molecules22101484
  +Save
• Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach.
  Pharmaceutical research 2017 DOI: 10.1007/s11095-017-2161-z
  +Save
• Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
  Molecules (Basel, Switzerland) 2017 DOI: 10.3390/molecules22030365
  +Save
• Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective.
  The pharmacogenomics journal 2016 DOI: 10.1038/tpj.2016.1
  +Save